Affinity Equity Partners, the private equity firm that acquired South Korea’s two largest rental car companies, is securing 1 ...
Carlyle and SK Capital Partners are buying beleaguered gene therapy biotech Bluebird Bio for about $29 million.
Bluebird bio (BLUE) shares continued their downward descent Monday following news that the company plans to be taken private through a deal valued at up to $96M. Read more here.
12 years after going public, beleaguered gene therapy company bluebird bio will be sold to private equity groups Carlyle and ...